Figure 3
From: Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncology
Generally preferred designs. (a) “All comers,” prospective marker-stratified design: (a) a prognostic test and (b) a predictive test. Adapted from ref. 40.
